How does the discontinuation of tamoxifen affect the chances of breast cancer recurrence?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18803859
Cited by: 0

Abstract

Discontinuation of tamoxifen may lead to increased breast cancer recurrence, though switching to alternative therapies or extending therapy duration might mitigate this risk, depending on individual patient factors.

Fields of Study & Subjects

Breast Cancer Treatment Studies Estrogen and related hormone effects Endometrial and Cervical Cancer Treatments

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
27 February 2026
Language
EN